Related Articles
Systemic symptoms in irritable bowel syndrome: An investigative study on the role of enterocyte disintegrity, endotoxemia and inflammation
[Editorial] Tackling key immunological and immuno-dermatological pathways and their link to treatment options
Reduced chromogranin A cell density in the ileum of patients with irritable bowel syndrome
Post‑infectious irritable bowel syndrome after a laboratory‑proven enteritis
Role of glucagon-like peptide-1 in the pathogenesis of experimental irritable bowel syndrome rat models